Brain Injuries, TraumaticCASVALNCT02957461
Validation of Brain Function Assessment Algorithm for mTBI/Concussion in College Athletes
An observational study of Brain Injuries, Traumatic and Concussion, Mild, run by BrainScope Company, Inc. at 8 sites in United States.
Trial summary
This study is Part 1 of data collection from 18-25 years old subject population for validation of previously derived algorithms. This data will be combined with that collected under NCT03671083 (Part 2 with subject age range 13-25 years) for the final analyses of validation of the algorithms. Read more about this study
- Who is it for?
- Ages 18 to 25 years
- Conditions the study is for
- Brain Injuries, Traumatic, Concussion, Mild, Concussion, Brain
- What is being tested?
- BrainScope Ahead 200iD
- Type of treatment
- Medical device
- How many people
- 420 participants
- Where
- 8 sitesUnited States
- Study dates
- 3 Feb 2017to 2 Mar 2018
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 25 years
- All sexes
- No healthy volunteers
- Adult
Study population: Approximately 220 male and female student-athletes from participating universities or colleges will be invited to participate.
Who may be able to join
- Time of injury within 72 hours of BrainScope Battery
- No evidence of abnormality visible on Computerized Tomography (CT) of the head related to the traumatic event (Note: neuroimaging is not required for enrollment)
- No hospital admission due to either head injury or collateral injuries for >24 hours
- GCS between 13-15
Who cannot join
- Previously enrolled as an Injured or Matched Control subject in the BrainScope Algorithm Development Study
- Current CNS active prescription medications taken daily, with the exception of medications being taken for the treatment of Attention Deficit Disorder (ADD) or Attention Deficit Hyperactivity Disorder (ADHD)
- Forehead, scalp or skull abnormalities that prevents headset application or EEG data collection
- History of brain surgery or neurological disease
- Pregnant women
- Do not speak or read English
- Loss of consciousness ≥ 20 minutes related to the concussion injury - for injured subjects only
- Prior history of concussion in the last year - for Matched Control subjects only
Trial locations and contacts
8 sites in 1 country.
8 sites in 1 country
United States8 sites
University of Texas - Austin
Austin, Texas, 78712
University of South Carolina
Columbia, South Carolina, 29208
Michigan State University
East Lansing, Michigan, 48824
University of Arkansas
Fayetteville, Arkansas, 72701
University of Rochester Medical Center
Rochester, New York, 14642
University of Connecticut
Storrs, Connecticut, 06269
SUNY Upstate Medical University
Syracuse, New York, 13210
University of South Florida
Tampa, Florida, 33612
About this study
Official title: Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
This study is Part 1 of data collection from 18-25 years old subject population for validation of previously derived algorithms. This data will be combined with that collected under NCT03671083 (Part 2 with subject age range 13-25 years) for the final analyses of validation of the algorithms.
Read the detailed description
EEG, neurocognitive performance and clinical data will be collected at time of injury (within 3 days) at clinically determined Return to Play (RTP) and 45 days after RTP, for the purpose of independently validating the performance of the algorithms developed in prior studies (NCT02477943, NCT02661633 and NCTXXXXXX). Data collected under this study will be combined with that collected under NCT03671083 for the final analyses of prospective algorithm performance in an independent population ages 13-25 years. Subjects will come from the sports and other populations of concussed individuals. They will be matched with controls i.e. not head injured subjects who will also undergo the same set of tests and the same time intervals as the injured subjects. An additional pool of uninjured (not head injured) subjects will be collected who will be assessed at a single time point.
- Conditions
- Brain Injuries, Traumatic, Concussion, Mild, Concussion, Brain, Concussion, Severe, Concussion, Intermediate
- Being tested
- BrainScope Ahead 200iD
- Keywords
- Concussion, Mild Traumatic Brain Injury, Sport Related Concussion
- Medical subject headings
- Brain Injuries, Traumatic, Brain Concussion
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
BrainScope Ahead 200iDDevice
The BrainScope Battery evaluation will consist of 4 tests to aid in the assessment of concussion: History, Physical, signs and symptoms (SAC, SCAT3), Electrophysiological Function; Neurocognitive Performance Assessment and Ocular Motor assessment. BrainScope Ahead 200iD device will be used to perform EEG.
| Study group | Role | What they receive |
|---|---|---|
| Injured and Matched Control Subject Pool | Injured subjects consist of athletes who are head injured and meet the inclusion/exclusion criteria. Injured subjects will be tested within 72 hours (3 days) of injury and at specified time points post injury. Matched control subjects will be tested at the same time intervals as the injured subject. BrainScope Battery will be performed at each time point and consists of the following components: brain electrical activity (EEG), neurocognitive performance assessment, ocular motor assessment, and clinical symptoms/assessments. Receives: Device: BrainScope Ahead 200iD | |
| Healthy Volunteer Subject Pool | This subject pool will consist of uninjured (not head injured) contact and non-contact athletes and will be tested at a single time point. These subjects will perform the same BrainScope Battery as the injured and matched control subjects. Receives: Device: BrainScope Ahead 200iD |
What is being measured
The primary outcome is the main question the study is designed to answer.
Likelihood of being concussed
Sensitivity and specificity forthe identification of the likelihood of concussion/mTBI at the time of injury using a multi-modal EEG-based Concussion Index (CI)
Measured: 6 months for data acquisition, with each patient studied from time of injury to 45 days after RTP
Secondary outcomes (2)
Significance of change over time
Significant difference in concussion index between time of injury and return to play (RTP)
Measured: 6 months for data acquisition, with each patient studied from time of injury to 45 days after RTP
Prediction of prolonged recovery
Accuracy of prediction of prolonged recovery from injury assessment using a multi-modal EEG-based concussion index
Measured: 6 months for data acquisition, with each patient studied from time of injury to 45 days after RTP
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Nov 2016 (estimated)
- Study start3 Feb 2017
- Primary completion31 Jan 2018
- Study completion2 Mar 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Brain Injuries, TraumaticStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 420 participants (actual)
Sponsor and investigators
- Lead sponsor
- BrainScope Company, Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- United States Department of Defense
- Responsible party
- Sponsor
- Investigators
- Leslie Prichep, Ph.D., Study director, BrainScope Company, Inc.
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02957461
- Sponsor's protocol ID
- 18-Ahead
- Acronym
- CASVAL
- Status last verified
- Aug 2018
- First submitted
- 3 Nov 2016
- Last updated
- 23 May 2019
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 23 May 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
- ClinicalTrials.gov ID
- NCT02957461
- Acronym / sponsor ID
- CASVAL / 18-Ahead
- Conditions
- Brain Injuries, Traumatic, Concussion, Mild, Concussion, Brain, Concussion, Severe, Concussion, Intermediate
- Keywords
- Concussion, Mild Traumatic Brain Injury, Sport Related Concussion
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 420 participants (actual)
- Lead sponsor
- BrainScope Company, Inc.Industry (pharma, biotech, devices)
- Collaborators
- United States Department of Defense
- Study start
- 3 Feb 2017 (actual)
- Primary completion
- 31 Jan 2018 (actual)
- Study completion
- 2 Mar 2018 (actual)
- First posted
- 7 Nov 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is Part 1 of data collection from 18-25 years old subject population for validation of previously derived algorithms. This data will be combined with that collected under NCT03671083 (Part 2 with subject age range 13-25 years) for the final analyses of validation of the algorithms.
Detailed description
EEG, neurocognitive performance and clinical data will be collected at time of injury (within 3 days) at clinically determined Return to Play (RTP) and 45 days after RTP, for the purpose of independently validating the performance of the algorithms developed in prior studies (NCT02477943, NCT02661633 and NCTXXXXXX). Data collected under this study will be combined with that collected under NCT03671083 for the final analyses of prospective algorithm performance in an independent population ages 13-25 years. Subjects will come from the sports and other populations of concussed individuals. They will be matched with controls i.e. not head injured subjects who will also undergo the same set of tests and the same time intervals as the injured subjects. An additional pool of uninjured (not head injured) subjects will be collected who will be assessed at a single time point.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Injured and Matched Control Subject Pool | – | Device: BrainScope Ahead 200iDInjured subjects consist of athletes who are head injured and meet the inclusion/exclusion criteria. Injured subjects will be tested within 72 hours (3 days) of injury and at specified time points post injury. Matched control subjects will be tested at the same time intervals as the injured subject. BrainScope Battery will be performed at each time point and consists of the following components: brain electrical activity (EEG), neurocognitive performance assessment, ocular motor assessment, and clinical symptoms/assessments. |
| Healthy Volunteer Subject Pool | – | Device: BrainScope Ahead 200iDThis subject pool will consist of uninjured (not head injured) contact and non-contact athletes and will be tested at a single time point. These subjects will perform the same BrainScope Battery as the injured and matched control subjects. |
Who may qualify
- Ages
- 18 to 25 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- Approximately 220 male and female student-athletes from participating universities or colleges will be invited to participate.
Key inclusion criteria (4 listed)
- Time of injury within 72 hours of BrainScope Battery
- No evidence of abnormality visible on Computerized Tomography (CT) of the head related to the traumatic event (Note: neuroimaging is not required for enrollment)
- No hospital admission due to either head injury or collateral injuries for >24 hours
- GCS between 13-15
Key exclusion criteria (8 listed)
- Previously enrolled as an Injured or Matched Control subject in the BrainScope Algorithm Development Study
- Current CNS active prescription medications taken daily, with the exception of medications being taken for the treatment of Attention Deficit Disorder (ADD) or Attention Deficit Hyperactivity Disorder (ADHD)
- Forehead, scalp or skull abnormalities that prevents headset application or EEG data collection
- History of brain surgery or neurological disease
- Pregnant women
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| BrainScope Ahead 200iDThe BrainScope Battery evaluation will consist of 4 tests to aid in the assessment of concussion: History, Physical, signs and symptoms (SAC, SCAT3), Electrophysiological Function; Neurocognitive Performance Assessment and Ocular Motor assessment. BrainScope Ahead 200iD device will be used to perform EEG. | Device | Healthy Volunteer Subject Pool, Injured and Matched Control Subject Pool |
Primary outcome
Likelihood of being concussed
Time frame: 6 months for data acquisition, with each patient studied from time of injury to 45 days after RTP
Sensitivity and specificity forthe identification of the likelihood of concussion/mTBI at the time of injury using a multi-modal EEG-based Concussion Index (CI)
2 secondary outcomes
Significance of change over time
Time frame: 6 months for data acquisition, with each patient studied from time of injury to 45 days after RTP
Prediction of prolonged recovery
Time frame: 6 months for data acquisition, with each patient studied from time of injury to 45 days after RTP
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 May 2019.
Related trials for Brain Injuries, Traumatic
RecruitingPhase 1
Rehabilitation Through Virtual Immersion & Integrated Exposure for Mild Traumatic Brain Injury (ReVIVE for mTBI)
Traumatic Brain Injuries, TBI (Traumatic Brain Injury)
Recruiting
Feasibility and Acceptability of an LLM-based Chatbot for Family Caregivers: Evaluation Study
Caregivers
Not yet recruitingObservational study
Prospective Observational Multimodal Neuromonitoring in Adult NSICU Patients
Subarachnoid Hemorrhage, Aneurysmal, Brain Injuries, Traumatic
Not yet recruitingObservational study
The Systemic Nature of Severe Traumatic Brain Injury
Severe Traumatic Brain Injury
Not yet recruitingObservational study
Cognitive Effects of Hyperbaric Oxygen Therapy (HBOT) After a Traumatic Brain Injury
Traumatic Brain Injury, Post-Concussion Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Leslie Prichep, Ph.D. study director
BrainScope Company, Inc.
8 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Brain Injuries, Traumatic and Concussion, Mild, run by BrainScope Company, Inc. at 8 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 May 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 8 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Likelihood of being concussed (time frame: 6 months for data acquisition, with each patient studied from time of injury to 45 days after RTP). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 May 2019.